BioSpace News Archive

Fluidigm Corporation announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in investor meetings and present updates regarding Fluidigm’s business strategy and financial performance at the following investor event.

LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, Type 1 diabetes, end stage renal disease, and aging, announced that it has achieved positive in vitro results of a novel combination drug-biologic product for patients with inborn errors of metabolism, adding these orphan pediatric indications to its drug development pipeline.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced the appointment of Massimo Mineo, a veteran of Europe’s pharmaceutical industry for 20+ years, as Napo EU’s general manager.

Tenax Therapeutics, Inc. today reported financial results for the third quarter of 2021 and provided a business update.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, today reported its 2021 third quarter unaudited financial results.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), today announced the results of a nonclinical research study showing that CRV431 significantly decreased the growth of liver tumors in a mouse model of liver cancer.

The Mitra® microsampling device from US-based Neoteryx has been registered in Brazil as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA, the Agência Nacional de Vigilância Sanitária (National Health Surveillance Agency)

Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce the advancement of the Psilonex™ RX human clinical phase I trial.

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, today announced that Hans Hofland, senior vice president, research, will present at the 42nd Annual Meeting of the American College of Toxicology and the 5th Annual Dermatology Drug Development Summit for Inflammatory Diseases this week.

Advantis Medical Imaging, a pioneering manufacturer of cloud-based medical imaging software solutions, today announced its first 510(k) clearance from the U.S. Food and Drug Administration (FDA).